Researchers Myrthe van Dijk

Myrthe van Dijk

Research Staff Other

Contact

Recent publications

Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell disease Myrthe J van Dijk, Titine J J Ruiter, Sigrid van der Veen, Minke A E Rab, Brigitte A van Oirschot, Jennifer Bos, Cleo Derichs, Anita W Rijneveld, Marjon H Cnossen, Erfan Nur, Bart J Biemond, Marije Bartels, Roger E G Schutgens, Wouter W van Solinge, Judith J M Jans, Eduard J van Beers, Richard van Wijk
Hemasphere, 2024, vol. 8

Exploring metabolic dysregulation and therapeutic targets in sickle cell disease and rare hereditary red blood cell disorders Myrthe van Dijk
2024

A novel composition of endogenous metabolic modulators improves red blood cell properties in sickle cell disease Myrthe J van Dijk, Marissa J M Traets, Brigitte A van Oirschot, Titine J J Ruiter, Jonathan R A de Wilde, Jennifer Bos, Wouter W van Solinge, Margaret J Koziel, Judith J M Jans, Revati Wani, Eduard J van Beers, Richard van Wijk, Minke A E Rab
EJHaem, 2024, vol. 5, p.21-32

Corrigendum to “Activation of pyruvate kinase as therapeutic option for rare hemolytic anemias Myrthe J. van Dijk, Jonathan R.A. de Wilde, Marije Bartels, Kevin H.M. Kuo, Andreas Glenthøj, Minke A.E. Rab, Eduard J. van Beers, Richard van Wijk
Blood Reviews, 2023, vol. 64

One-year safety and efficacy of mitapivat in sickle cell disease Myrthe J van Dijk, Minke A E Rab, Brigitte A van Oirschot, Jennifer Bos, Cleo Derichs, Anita W Rijneveld, Marjon H Cnossen, Erfan Nur, Bart J Biemond, Marije Bartels, Judith J M Jans, W W van Solinge, Roger E G Schutgens, Richard van Wijk, Eduard J van Beers
Blood Advances, 2023, vol. 7, p.7539-7550

Activation of pyruvate kinase as therapeutic option for rare hemolytic anemias Myrthe J van Dijk, Jonathan R A de Wilde, Marije Bartels, Kevin H M Kuo, Andreas Glenthøj, Minke A E Rab, Eduard J van Beers, Richard van Wijk
Blood Reviews, 2023, vol. 61